Sun Pharmaceutical Industries

Phone: +91 22 4324 4324; +91 22 4324 4343

Web: https://sunpharma.com/

Type	Public
Traded as	BSE: 524715 NSE: SUNPHARMA BSE SENSEX Constituent NSE NIFTY 50 Constituent
ISIN	INE044A01036
Industry	Pharmaceuticals
Founded	1983 (1983)
Founder	Dilip Shanghvi
Headquarters	Mumbai, India
Area served	Worldwide
Key people	Dilip Shanghvi (MD)
Products	Pharmaceuticals Branded generic drugs over-the-counter drugs Speciality drugs OTCs APIs ARVs
Revenue	₹39,576 crore (US$5.0 billion) (2022)
Operating income	₹4,481 crore (US$560 million) (2022)
Net income	₹3,405 crore (US$430 million) (2022)
Total assets	₹69,799 crore (US$8.7 billion) (2022)
Total equity	₹48,011 crore (US$6.0 billion) (2022)
Number of employees	37,000+ (2021)
Website	sunpharma.com

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion. Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

For detailed contact information visit location pages below.